Background:
Patients treated in ICU often suffer from malignancies. Infections are among the most frequent complications occurring in cancer patients undergoing antineoplastic chemo-or immunotherapy. Objectives: The aim of this study was to investigate the prevalence of ICU-acquired infections these patients suffer from after a surgical operation or an immunosupressive treatment. Methods: Twenty-four patients suffering from malignancies (Ca, lymphomas, multiple myeloma, etc.) were admitted to the ICU during the last two years. Clinical samples (blood, urine, central venous catheter, drainage, bronchial lavage etc.) were obtained from 13 of them. Specimens were inoculated and incubated according to standard bacteriological methods. Identification and susceptibility testing of culture isolates was performed by VITEK semi-automatic system in accordance with the CLSI guidelines. Results: Pathogens were isolated in 11 of 13 patients (84.6%). One to five pathogens were isolated in each patient. 13 of them were Gram-positive bacteria (25%), 8 were Gram-negative bacteria (32%) and 4 were Candida spp (16%). Pathogens detected are presented in the table: Staphylococci isolated were all coagulase negative and oxacilline resistant. Strains of E. coli and K. pneumoniae isolated revealed to produce extended-spectrum b-lactamases (ESBLs) whereas Ps.aeruginosa produced metallo-b-lactamases (MBLs). Furthrmore all Acinetobacter isolated were multiresistant. Conclusions: Most common pathogens were Gram-positive bacteria, especially coagulase negative staphylococci, followed by enterobacteriaceae. Most prevalent were bloodstream infections, local CVC-related infections and pneumonias whereas less prevalent were urinary tract infections. Exposure of immunocompromised patients to invasive devices in ICUs, such as multi-lumen central venous catheters, contributes to increased rate of infections by highly resistant pathogens (ESBL, MBL, oxacilline resistant) and high mortality rate. Our study confirms the essential role of epidemiologic surveillance and infection control. 
Methods and Results:
Bacterial infections during chemotherapy were alpha streptococcal bacteremia, VRE colonisation and Klebsiella bacteremia. Three months into therapy the child fell on dirt and sustained minor asymptomatic skin abrasions over knee and chin. Six weeks later during phase of neutropenia, presented with painful swelling of left lower jaw with painful localised eschar over chin and prepatellar region. Excision biopsy of cutaneous lesions and gingival biopsy revealed fungal hyphae (see tables 1&2). Aspergillus PCR in tissue specimen and Antigen detection in blood were negative. Tissue biopsy was culture positive for two fungal pathogens, Fusarium and Rhizopus. MRI of mandible was consistent with osteomyelitis. Aggressive treatment with multiple debridement procedures of the mandible, including dental extractions, granulocyte transfusions 5 days/week, lipid formulation amphotericin (10mg/kg/dose), followed by GCSF and tooth extractions resolved the infection 16 weeks later. On day 6 of therapy she developed fever, neutropenia and Bacillus cereus bacteremia. For this broad spectrum antibiotics were started but no antifungal prophylaxis was begun. During the next week she developed progressive abdominal pain, rib pain, shortness of breath, malaise until on day 14 when RLL infiltrates were noted on Chest X-Ray. Bronchoscopy was negative for fungal elements. CT scan of chest and abdomen revealed massive hepatosplenic infarction and large RLL consolidation (see figure 1) . This was associated with a rapid rise in transaminases and hyperammonemia, elevated CRP (see table) . Open lung and wedge biopsy of liver was done revealing subtotal hemorrhagic necrosis with widespread angioinvasive pleomorphic fungal hyphal forms (figure 2). In the immediate postoperative period she developed liver failure and succumbed to irreversible shock. Lung and liver tissue cultures obtained during biopsy cultured positive for Mucor species. Background: Because of an outbreak of Extended Spectrum of Betalactamase producing (ESBL) E. coli and Klebsiella pneumonia emerged in the Hospital, the routine use of fluoroquinolone prophylaxis was questioned. To evaluate the use of fluoroquinolone prophylaxis and as a background for further recommendations, this retrospective study was performed in patients with acute leukaemia after induction therapy at a single-centre. The aim was to study if there were differences in the use of empiric antibacterial therapy whether prophylaxis was given or not, fever episodes and infections. Methods: Fifty-nine episodes of neutropenia following induction therapy for acute leukaemia were studied during the 2-year pe- Background: Typhlitis, is a necrotizing inflammation of the colon, almost invariably associated with underlying malignancy, intensive chemotherapy, and severe neutropenia. Currently, limited data are available on the incidence, outcome, and risk factors of typhlitis in children with cancer. Previous studies addressing this issue did not take into account the current changes in cancer treatment protocols and were based on a limited number of cases. Objectives: To define the epidemiological and clinical features of
